ERBB2 and neoplasm: However, ki‐67 data was not provided in the METABRIC cohort and the statistical analysis suggested that the effect of pathological grade and HR/HER2 status on TP53 mutation was consistent with GDPH (P < 0.01), and there was no correlation between tumor stage and mutation of TP53 (P > 0.05).